Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Verapamil ER for Morning Hypertension (Phase II, China)
CTR20140516Phase 2Active
- Sponsor
- Yuanhe Pharmaceutical
- Start
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of verapamil in essential hypertension, sponsored by Yuanhe Pharmaceutical. Started Nov 2014; status: active.
02
Drugs
verapamil
03
Conditions
essential hypertension
Beyond the preview
Go deeper on CTR20140516.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140516.